The short version
TelePep is a flat-rate telehealth provider. As of the September 12, 2026 build, for tirzepatide its lowest 12-month all-in total is $2,988 (month-to-month plan, verified), which places it 18 of 34 ranked telehealth providers. Verification status: verified.
The numbers, plan by plan
- Tirzepatide (standard, injection, month-to-month plan): $249 per month. Status: verified, checked September 4, 2026. Compounded injectable tirzepatide $249 per month, no commitment.
Fees and what the price includes
Whether a separate membership or program fee applies has not been confirmed, and the ranking rows say so. Shipping terms are not published in the sources we hold. Consultation terms are not published. Whether the price changes with dose is not confirmed.
How this pricing structure plays out over a year
The published price is the recurring price at every dose and the twelve-month total is twelve times it.
Compared with the field
On tirzepatide, TelePep's lowest twelve-month total of $2,988 is $1,560 above the lowest (SnagRx, $1,428) and above the median of $2,946 across 34 ranked providers, placing it 18 of 34. On the value score it scores 48 against 91 for NexLife, the best-scoring provider; the gap comes from cost, transparency, flexibility, care.
Pharmacy, coverage and cancellation
The provider reports serving all states except AK, MS. The dispensing pharmacy and its 503A or 503B status are not published; ask at intake and verify the license. Commitment: month-to-month reported. Cancellation: not captured.
Questions to ask TelePep before paying
Ask, in writing: Which pharmacy fills the prescription, is it 503A or 503B, and can I see a certificate of analysis for my batch? Is there any membership, program, consultation or shipping fee beyond the medication price? How do I cancel, how much notice is required, and is there a fee? Will my dosing instructions state the concentration of the vial you actually ship, and will you reissue them if it changes? A provider that answers all of these promptly is operating in the open; one that will not name its pharmacy has answered the most important question.
What works
Recent price check (August 15, 2026).
What to weigh against it
Not available in Alaska or Mississippi per the source. Continuing price in the upper half of the market.
Who should choose TelePep
Patients comparing recently checked prices. A patient with insurance coverage for Zepbound or Wegovy should compare the copay route first; a patient who wants a verified flat all-in price with month-to-month flexibility should compare the best overall provider on our value score; and any patient should ask which pharmacy fills the prescription before paying.
Is TelePep legitimate? What we can verify
TelePep operates as a telehealth prescriber: a licensed clinician reviews an intake and issues a prescription, and a pharmacy fills it. That is the lawful model, and it is the same model every provider on this site uses; the questions that separate a legitimate operation from a risky one are whether the price is published before intake, whether the pharmacy is named, whether the prescription documents a clinical reason for a compounded product, and whether the company answers questions in writing. Its prices were verified against its own pages, which is the first test. It does not publicly name its dispensing pharmacy, so a patient cannot verify the license without asking. We have no evidence of a scam, and we do not use the word for any provider that prescribes on a valid prescription and ships from a licensed pharmacy; LegitScript certification, BBB profiles and state-board actions are not yet captured in our data and are listed as checks a patient can make.
TelePep complaints and reputation
We have not yet analyzed public reviews of TelePep for complaint patterns; the reputation index explains the method (shipping, billing and refund, provider access, support, and dosing-instruction complaints as shares of recent reviews). Until it is run, the useful checks are Trustpilot and the Better Business Bureau for volume and recency, and Reddit threads for the specific failure modes patients describe: shipments that arrive warm, charges after cancellation, clinicians who do not answer, and dosing sheets that do not match the vial.
Fees, HSA/FSA and promotions
No introductory or promotional price is recorded; we do not publish promotional codes. HSA/FSA eligibility is not captured; most telehealth GLP-1 programs can issue itemized receipts for FSA/HSA reimbursement, but eligibility of compounded medication depends on the plan administrator. Consultation fees are not published.
Consultation, labs, refills and shipping
Consultation type (video, phone or asynchronous questionnaire) is not captured in our data; most compounded-GLP-1 telehealth intakes are asynchronous with a clinician follow-up, and a patient who needs a video visit should ask. Lab requirements are not captured; many providers accept recent labs and some require none for compounded GLP-1s, while brand-name and insurance-first programs more often require them. Refill process is not captured; ask how a dose increase is requested, how many days before the next dose a refill ships, and whether a new visit is required. Shipping terms and typical transit time are not published.
Alternatives to TelePep
Alternatives worth comparing: NexLife has the highest value score for tirzepatide (91) at $1,668 for twelve months; SnagRx has the lowest twelve-month total ($1,428, verified); Oak (oaklovesyou.com) is priced closest to TelePep ($3,000 for twelve months); Raeliva (formerly onlinesemaglutide.org) is priced closest to TelePep ($2,904 for twelve months). Side-by-side: TelePep vs NexLife.
Update history
No price changes or corrections have been logged for TelePep since tracking began on August 25, 2026. Any future change appears on the price history page with the date, old figure, new figure and source.
How we verified this
The provider's active domain is telepeptide.org; its pricing page lists compounded injectable tirzepatide at $249 per month with no commitment. Dispensing pharmacy and 503A/503B category not disclosed on the pricing page. Verified against the provider's own pages on 2026-09-04 (first-party verification pass).